The Family Firm’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,068
| Closed | -$882K | – | 152 |
|
|
2025
Q1 | $882K | Buy |
1,068
+2
| +0.2% | +$1.65K | 0.2% | 82 |
|
|
2024
Q4 | $823K | Sell |
1,066
-58
| -5% | -$44.8K | 0.18% | 82 |
|
|
2024
Q3 | $996K | Buy |
1,124
+121
| +12% | +$107K | 0.22% | 77 |
|
|
2024
Q2 | $908K | Buy |
1,003
+1
| +0.1% | +$905 | 0.2% | 80 |
|
|
2024
Q1 | $779K | Buy |
1,002
+1
| +0.1% | +$778 | 0.19% | 88 |
|
|
2023
Q4 | $583K | Buy |
1,001
+2
| +0.2% | +$1.17K | 0.15% | 96 |
|
|
2023
Q3 | $537K | Buy |
999
+1
| +0.1% | +$537 | 0.15% | 96 |
|
|
2023
Q2 | $468K | Buy |
998
+2
| +0.2% | +$938 | 0.12% | 106 |
|
|
2023
Q1 | $342K | Sell |
996
-17
| -2% | -$5.84K | 0.09% | 130 |
|
|
2022
Q4 | $371K | Buy |
1,013
+2
| +0.2% | +$732 | 0.11% | 125 |
|
|
2022
Q3 | $327K | Buy |
1,011
+2
| +0.2% | +$647 | 0.1% | 129 |
|
|
2022
Q2 | $327K | Buy |
1,009
+3
| +0.3% | +$972 | 0.1% | 134 |
|
|
2022
Q1 | $288K | Buy |
1,006
+2
| +0.2% | +$573 | 0.08% | 146 |
|
|
2021
Q4 | $277K | Buy |
1,004
+3
| +0.3% | +$828 | 0.07% | 147 |
|
|
2021
Q3 | $244K | Buy |
1,001
+2
| +0.2% | +$488 | 0.06% | 161 |
|
|
2021
Q2 | $229K | Buy |
+999
| New | +$229K | 0.06% | 162 |
|